Literature DB >> 31108085

Neuroimmune responses in the developing brain following traumatic brain injury.

Isam W Nasr1, Young Chun1, Sujatha Kannan2.   

Abstract

Traumatic brain injury (TBI) is one of the leading causes of both acute and long-term morbidity in the pediatric population, leading to a substantial, long-term socioeconomic burden. Despite the increase in the amount of pre-clinical and clinical research, treatment options for TBI rely heavily on supportive care with very limited targeted interventions that improve the acute and chronic sequelae of TBI. Other than injury prevention, not much can be done to limit the primary injury, which consists of tissue damage and cellular destruction. Secondary injury is the result of the ongoing complex inflammatory pathways that further exacerbate tissue damage, resulting in the devastating chronic outcomes of TBI. On the other hand, some level of inflammation is essential for neuronal regeneration and tissue repair. In this review article we discuss the various stages of the neuroimmune response in the immature, pediatric brain in the context of normal maturation and development of the immune system. The developing brain has unique features that distinguish it from the adult brain, and the immune system plays an integral role in CNS development. Those features could potentially make the developing brain more susceptible to worse outcomes, both acutely and in the long-term. The neuroinflammatory reaction which is triggered by TBI can be described as a highly intricate interaction between the cells of the innate and the adaptive immune systems. The innate immune system is triggered by non-specific danger signals that are released from damaged cells and tissues, which in turn leads to neutrophil infiltration, activation of microglia and astrocytes, complement release, as well as histamine release by mast cells. The adaptive immune response is subsequently activated leading to the more chronic effects of neuroinflammation. We will also discuss current attempts at modulating the TBI-induced neuroinflammatory response. A better understanding of the role of the immune system in normal brain development and how immune function changes with age is crucial for designing therapies to appropriately target the immune responses following TBI in order to enhance repair and plasticity.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Developing brain; Immature immune response; Microglia; Neuroinflammatory response; Pediatric TBI

Year:  2019        PMID: 31108085     DOI: 10.1016/j.expneurol.2019.112957

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  17 in total

1.  Toll-like Receptor 4 Signaling in Neurons Enhances Calcium-Permeable α-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Currents and Drives Post-Traumatic Epileptogenesis.

Authors:  Akshata A Korgaonkar; Ying Li; Dipika Sekhar; Deepak Subramanian; Jenieve Guevarra; Bogumila Swietek; Alexandra Pallottie; Sukwinder Singh; Kruthi Kella; Stella Elkabes; Vijayalakshmi Santhakumar
Journal:  Ann Neurol       Date:  2020-02-24       Impact factor: 10.422

2.  Early life stress increases vulnerability to the sequelae of pediatric mild traumatic brain injury.

Authors:  Arturo Diaz-Chávez; Naima Lajud; Angélica Roque; Jeffrey P Cheng; Esperanza Meléndez-Herrera; Juan José Valdéz-Alarcón; Corina O Bondi; Anthony E Kline
Journal:  Exp Neurol       Date:  2020-04-16       Impact factor: 5.330

3.  Early Life Stress Preceding Mild Pediatric Traumatic Brain Injury Increases Neuroinflammation but Does Not Exacerbate Impairment of Cognitive Flexibility during Adolescence.

Authors:  Naima Lajud; Angélica Roque; Jeffrey P Cheng; Corina O Bondi; Anthony E Kline
Journal:  J Neurotrauma       Date:  2020-11-06       Impact factor: 5.269

4.  Modulation of astrocyte phenotype in response to T-cell interaction.

Authors:  Jessica Hersh; Jude Prah; Ali Winters; Ran Liu; Shao-Hua Yang
Journal:  J Neuroimmunol       Date:  2020-12-18       Impact factor: 3.478

5.  Annexin A2 depletion exacerbates the intracerebral microhemorrhage induced by acute rickettsia and Ebola virus infections.

Authors:  Zhengchen Su; Qing Chang; Aleksandra Drelich; Thomas Shelite; Barbara Judy; Yakun Liu; Jie Xiao; Changchen Zhou; Xi He; Yang Jin; Tais Saito; Shaojun Tang; Lynn Soong; Maki Wakamiya; Xiang Fang; Alexander Bukreyev; Thomas Ksiazek; William K Russell; Bin Gong
Journal:  PLoS Negl Trop Dis       Date:  2020-07-20

Review 6.  Stem Cell Therapy for Pediatric Traumatic Brain Injury.

Authors:  Dana Lengel; Cruz Sevilla; Zoe L Romm; Jimmy W Huh; Ramesh Raghupathi
Journal:  Front Neurol       Date:  2020-12-02       Impact factor: 4.003

Review 7.  Progenitor cell therapy for acquired pediatric nervous system injury: Traumatic brain injury and acquired sensorineural hearing loss.

Authors:  James E Baumgartner; Linda S Baumgartner; Michael E Baumgartner; Ernest J Moore; Steven A Messina; Michael D Seidman; David R Shook
Journal:  Stem Cells Transl Med       Date:  2020-10-09       Impact factor: 6.940

8.  A Mouse Model for Juvenile, Lateral Fluid Percussion Brain Injury Reveals Sex-Dependent Differences in Neuroinflammation and Functional Recovery.

Authors:  Elizabeth A Newell; Brittany P Todd; Zili Luo; Lucy P Evans; Polly J Ferguson; Alexander G Bassuk
Journal:  J Neurotrauma       Date:  2019-12-05       Impact factor: 4.869

9.  Acute Traumatic Brain Injury-Induced Neuroinflammatory Response and Neurovascular Disorders in the Brain.

Authors:  Duraisamy Kempuraj; Mohammad Ejaz Ahmed; Govindhasamy Pushpavathi Selvakumar; Ramasamy Thangavel; Sudhanshu P Raikwar; Smita A Zaheer; Shankar S Iyer; Raghav Govindarajan; Premkumar Nattanmai Chandrasekaran; Casey Burton; Donald James; Asgar Zaheer
Journal:  Neurotox Res       Date:  2020-09-21       Impact factor: 3.911

Review 10.  Microglial Metabolism After Pediatric Traumatic Brain Injury - Overlooked Bystanders or Active Participants?

Authors:  Aria C Shi; Ursula Rohlwink; Susanna Scafidi; Sujatha Kannan
Journal:  Front Neurol       Date:  2021-01-25       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.